Roquinimex (Linomide; PNU212616; ABR212616) is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity; inhibits angiogenesis and reduces the secretion of TNF alpha.
For research use only. We do not sell to patients.
| Name | Roquinimex |
|---|---|
| Iupac Chemical Name | Roquinimex |
| Synonyms | Linomide; FCF89; LS2616; ABR212616; PNU212616 |
| Molecular Formula | C18H16N2O3 |
| Molecular Weight | 308.33 |
| Smile | Cn1c2ccccc2c(c(c1=O)C(=O)N(C)c3ccccc3)O |
| InChiKey | SGOOQMRIPALTEL-UHFFFAOYSA-N |
| InChi | InChI=1S/C18H16N2O3/c1-19(12-8-4-3-5-9-12)17(22)15-16(21)13-10-6-7-11-14(13)20(2)18(15)23/h3-11,21H,1-2H3 |
| CAS Number | 84088-42-6 |
| MDL | MFCD00866331 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | crystalline solid |
|---|---|
| Purity | 98% |
| Storage | 3 years -20ºCpowder |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |